Aldesleukin Terminated Phase 2 Trials for Neuroblastomas Treatment

IndicationsStatusPurposePhase
TerminatedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00698009Haploidentical Natural Killer (NK) Cells in Patients With Relapsed or Refractory Neuroblastoma
NCT02641782NB2013-HR German (GPOH) / Dutch (DCOG) Trial